These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8426953)

  • 1. The impact of the HLA-system in clinical medicine.
    van Rood JJ
    Schweiz Med Wochenschr; 1993 Jan; 123(3):85-92. PubMed ID: 8426953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supportive haemotherapy in bone marrow transplantation.
    Mayr WR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):455-8. PubMed ID: 2480289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA typing.
    Shaw JF
    Arch Pathol Lab Med; 1976 Jul; 100(7):341-5. PubMed ID: 59584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human leucocyte antigen (HLA) system.
    Turner D
    Vox Sang; 2004 Jul; 87 Suppl1():87-90. PubMed ID: 15200613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA system in blood transfusion.
    Navarrete CV
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):511-32. PubMed ID: 11102274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the HLA system in transfusion and bone marrow transplantation].
    Perreault C
    Union Med Can; 1981 Apr; 110(4):318-24. PubMed ID: 7018047
    [No Abstract]   [Full Text] [Related]  

  • 7. Human histocompatibility antigens (HLA).
    Kumar R; Mittal KK
    Indian Pediatr; 1983 Oct; 20(10):763-70. PubMed ID: 6373600
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA matching for bone marrow transplantation--how much is enough?
    Rubinstein P
    N Engl J Med; 2001 Dec; 345(25):1842-4. PubMed ID: 11752363
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenetics.
    van Rood JJ
    Curr Opin Hematol; 1994 Nov; 1(6):429-34. PubMed ID: 9371318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ever-expanding list of HLA alleles: changing HLA nomenclature and its relevance to clinical transplantation.
    Tait BD
    Transplant Rev (Orlando); 2011 Jan; 25(1):1-8. PubMed ID: 21030236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HLA and associated diseases--progress in molecular biology].
    Möller E; Olerup O
    Nord Med; 1990; 105(1):10-2. PubMed ID: 2300433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HLA matched donor! An HLA matched donor? What do you mean by: HLA matched donor?
    van Rood JJ; Oudshoorn M
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S83. PubMed ID: 9715900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory methods in transplantation immunity.
    Cannady WG; DeWolf WC; Williams RM; Yunis EJ
    Prog Clin Pathol; 1978; 7():239-65. PubMed ID: 345348
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature.
    Zaja F; Barillari G; Russo D; Silvestri F; Fanin R; Baccarani M
    Acta Neurol Scand; 1997 Oct; 96(4):256-9. PubMed ID: 9325479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor?
    Tiercy JM; Bujan-Lose M; Chapuis B; Gratwohl A; Gmür J; Seger R; Kern M; Morell A; Roosnek E
    Bone Marrow Transplant; 2000 Aug; 26(4):437-41. PubMed ID: 10982291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation.
    Taaning E; Jacobsen N
    Transplant Proc; 1994 Jun; 26(3):1826. PubMed ID: 8030157
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.
    Nakazawa Y; Saito S; Hasegawa Y; Yanagisawa R; Sakashita K; Kamijo T; Miyazaki T; Sato S; Ikeda H; Ikebuchi K; Koike K
    Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen and its role in transplantation biology.
    Trivedi VB; Dave AP; Dave JM; Patel BC
    Transplant Proc; 2007 Apr; 39(3):688-93. PubMed ID: 17445574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.